chlorpromazine has been researched along with Idiopathic Parkinson Disease in 87 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The anti-tremor potency of the compounds was assessed from suppression of Tremorine-induced tremors in mice." | 7.64 | Relationship between anti-acetylcholine and anti-Tremorine activity in anti-parkinsonian and related drugs. ( AHMED, A; MARSHALL, PB, 1962) |
| " The anti-tremor potency of the compounds was assessed from suppression of Tremorine-induced tremors in mice." | 3.64 | Relationship between anti-acetylcholine and anti-Tremorine activity in anti-parkinsonian and related drugs. ( AHMED, A; MARSHALL, PB, 1962) |
| "However, the performances of Huntington's disease subjects appeared to be different when compared to the other two groups." | 2.69 | Kinematic analysis of the reach to grasp movement in Parkinson's and Huntington's disease subjects. ( Bonfiglioli, C; Castiello, U; De Berti, G; Nichelli, P; Nicoletti, R, 1998) |
| "(ii) The effect of schizophrenia is to increase MAE duration, and this is not due to some peripheral artefact." | 2.39 | The duration of the movement aftereffect as an index of psychiatric illness. ( Harris, J, 1994) |
| "While neurodegenerative diseases affect millions of patients worldwide, there are insufficient available therapeutics to halt or slow down the progression of these diseases." | 1.72 | Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies. ( Jones, CL; Staerz, SD; Tepe, JJ, 2022) |
| "In addition to the diagnosis of chronic pseudoakathisia, five patients (62." | 1.31 | Prevalence and characteristics of patients with pseudoakathisia. ( Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP, 2000) |
| "Levodopa-induced dyskinesias (LID) in Parkinson's disease (PD) may be classified into three main categories: "On" dyskinesias, diphasic dyskinesias (DD), and "off" periods." | 1.28 | Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. ( Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 79 (90.80) | 18.7374 |
| 1990's | 4 (4.60) | 18.2507 |
| 2000's | 1 (1.15) | 29.6817 |
| 2010's | 2 (2.30) | 24.3611 |
| 2020's | 1 (1.15) | 2.80 |
| Authors | Studies |
|---|---|
| Staerz, SD | 1 |
| Jones, CL | 1 |
| Tepe, JJ | 1 |
| Rukmangathen, R | 1 |
| Yallamalli, IM | 1 |
| Yalavarthi, PR | 1 |
| Lv, H | 1 |
| Yu, F | 1 |
| Sha, C | 1 |
| Huang, Y | 1 |
| Lu, Y | 1 |
| Zhang, L | 1 |
| Zhai, R | 1 |
| Wang, T | 1 |
| Fu, F | 1 |
| BALESTRIERI, A | 1 |
| MONTANARI, M | 1 |
| BERGOUIGNAN, M | 1 |
| DE BOUCAUD, P | 1 |
| FOURNIAL, P | 1 |
| BENTE, D | 1 |
| ITIL, T | 1 |
| MEGGIO, B | 1 |
| CATTANI, F | 1 |
| HAASE, HJ | 3 |
| MAY, RH | 1 |
| VOEGELE, GE | 1 |
| FREYHAN, FA | 4 |
| SOMOGYI, I | 1 |
| TASS, G | 1 |
| NAHUNEK, K | 1 |
| RYBAKOVA, V | 1 |
| HASKOVEC, L | 1 |
| KNAUF, HW | 1 |
| LIT, AC | 1 |
| CAHAN, RB | 1 |
| PARRISH, DD | 1 |
| GUGGENHEIM, P | 1 |
| COHEN, L | 1 |
| GOLDSCHMIDT, D | 1 |
| AHMED, A | 1 |
| MARSHALL, PB | 1 |
| DI PERRI, R | 2 |
| GIAQUINTO, S | 1 |
| MERIAUX, J | 1 |
| NAVARRANNE, P | 1 |
| STRATAS, NE | 1 |
| PHILLIPS, RD | 1 |
| WALKER, PA | 1 |
| SANDIFER, MG | 1 |
| MANGHI, E | 1 |
| FLUGEL, F | 1 |
| POURSINES, Y | 1 |
| ALLIEZ, J | 1 |
| TOGA, M | 1 |
| Sheppard, C | 1 |
| Merlis, S | 1 |
| Rajput, AH | 1 |
| Rozdilsky, B | 1 |
| Hornykiewicz, O | 1 |
| Shannak, K | 1 |
| Lee, T | 1 |
| Seeman, P | 1 |
| Barbosa, ER | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| de Assis, JL | 1 |
| Young, SN | 1 |
| Gauthier, S | 1 |
| Chouinard, G | 1 |
| Anderson, GM | 1 |
| Purdy, WC | 1 |
| Atadzhanov, M | 1 |
| Campbell, DJ | 1 |
| Mendelsohn, FA | 1 |
| Adam, WR | 1 |
| Funder, JW | 1 |
| Harris, J | 1 |
| Gorchein, A | 1 |
| Bonfiglioli, C | 1 |
| De Berti, G | 1 |
| Nichelli, P | 1 |
| Nicoletti, R | 1 |
| Castiello, U | 1 |
| Havaki-Kontaxaki, BJ | 1 |
| Kontaxakis, VP | 1 |
| Christodoulou, GN | 1 |
| Hebenstreit, G | 1 |
| Nagatsu, T | 1 |
| Kanamori, T | 1 |
| Kato, T | 1 |
| Iizuka, R | 1 |
| Narabayashi, H | 1 |
| Martin, IC | 1 |
| Stadler, H | 1 |
| Ciria, MG | 1 |
| Bartholini, G | 2 |
| Beasley, BA | 1 |
| Ford, DH | 1 |
| Duvoisin, RC | 2 |
| Pakszys, W | 1 |
| Paulson, GW | 1 |
| Rizvi, CA | 1 |
| Crane, GE | 1 |
| Arushanian, EB | 2 |
| Luquin, MR | 1 |
| Scipioni, O | 1 |
| Vaamonde, J | 1 |
| Gershanik, O | 1 |
| Obeso, JA | 1 |
| Poirier, LJ | 1 |
| Stern, J | 1 |
| Mendell, J | 1 |
| Clark, K | 1 |
| Vogt, M | 1 |
| Carlsson, A | 1 |
| Van Loon, GR | 1 |
| Bruck, H | 1 |
| Gerstenbrand, F | 1 |
| Gnad, H | 1 |
| Gründig, E | 1 |
| Prosenz, P | 1 |
| Turunen, S | 1 |
| Achté, KA | 1 |
| Klawans, HL | 1 |
| Jurna, I | 1 |
| Nell, T | 1 |
| Schreyer, I | 1 |
| Sourkes, TL | 1 |
| Pakkenberg, H | 1 |
| Bottcher, J | 1 |
| Proctor, P | 1 |
| McGinness, J | 1 |
| Corry, P | 1 |
| McClelland, HA | 1 |
| Blessed, G | 1 |
| Bhate, S | 1 |
| Ali, N | 1 |
| Clarke, PA | 1 |
| Kelly, JT | 1 |
| Zimmermann, RL | 1 |
| Abuzzahab, FS | 1 |
| Schiele, BC | 1 |
| Singh, P | 2 |
| McDevitt, D | 1 |
| Mackay, J | 2 |
| Hadden, DR | 2 |
| Thody, AJ | 1 |
| Shuster, S | 1 |
| Messiha, FS | 1 |
| Turek, I | 1 |
| Morrison, AB | 1 |
| Webster, RA | 1 |
| McDevitt, DG | 1 |
| Ambani, LM | 1 |
| Van Woert, MH | 1 |
| Bowers, MB | 1 |
| Marsden, CD | 1 |
| Ganev, G | 1 |
| Karamalakov, L | 1 |
| Milenkov, K | 1 |
| Ianachkova, M | 1 |
| Sakhatchieva, L | 1 |
| Kiuchukova, P | 1 |
| Roĭlev, I | 1 |
| Naumov, I | 1 |
| Cheshmedzhiev, P | 1 |
| Dochkov, Zh | 1 |
| Brindle, GF | 1 |
| Jones, AB | 1 |
| Pare, CM | 2 |
| Nicholson, WJ | 1 |
| Price, K | 1 |
| Stacey, RS | 1 |
| Steg, G | 1 |
| Roos, BE | 1 |
| Blum, B | 1 |
| Weizmann, H | 1 |
| Simpson, GM | 1 |
| Krasilowsky, D | 1 |
| Kulcsar, IS | 1 |
| Merskey, H | 1 |
| Bruno, A | 1 |
| Bruno, SC | 1 |
| Chase, TN | 1 |
| Schnur, JA | 1 |
| Gordon, EK | 1 |
| Tissot, R | 1 |
| Culebras, A | 1 |
| Ialdygina, AS | 1 |
| Pervomaĭskiĭ, BIa | 1 |
| Antropov, IuA | 1 |
| Hader, M | 1 |
| Puca, FM | 1 |
| Oehme, P | 1 |
| Schwarz, K | 1 |
| Ekdawi, MY | 1 |
| Fowke, R | 1 |
11 reviews available for chlorpromazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Modeling parkinsonism (review)].
Topics: Aluminum; Animals; Carbachol; Cats; Caudate Nucleus; Chlorides; Chlorpromazine; Disease Models, Anim | 1982 |
Is aldosterone secretion under dopaminergic control?
Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; | 1981 |
The duration of the movement aftereffect as an index of psychiatric illness.
Topics: Adult; Antiparkinson Agents; Attention; Chlorpromazine; Dopamine; Eye Movements; Female; Fixation, O | 1994 |
[The use of psychotropic drugs in general practice].
Topics: Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Anxiety; Benzhydryl Compounds; Benzodiazepines; Bi | 1977 |
Aging and the extrapyramidal system.
Topics: Aged; Aging; Basal Ganglia Diseases; Chlorpromazine; Chorea; Dopamine; Frontal Lobe; Gait; Haloperid | 1976 |
Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Brain; Cats; Caudate Nucleus; Cerebellar Nuclei; Chlor | 1974 |
Release from brain tissue of compounds with possible transmitter function: interaction of drugs with these substances.
Topics: Acetylcholine; Animals; Brain; Brain Chemistry; Chlorpromazine; Dopamine; Humans; Norepinephrine; Pa | 1969 |
[The role of dopamine in the physiology and pathology of the basal ganglia].
Topics: Basal Ganglia; Brain; Caudate Nucleus; Chlorpromazine; Corpus Striatum; Dihydroxyphenylalanine; Dopa | 1972 |
Biochemical and pharmacological aspects of Parkinsonism.
Topics: Animals; Blood-Brain Barrier; Brain; Central Nervous System; Chemoreceptor Cells; Chlorpromazine; Co | 1972 |
The role of brain catecholamines in the regulation of ACTH secretion.
Topics: 17-Hydroxycorticosteroids; Acetylcholine; Adrenal Cortex Hormones; Adrenal Glands; Adrenalectomy; Ad | 1974 |
The pharmacology of parkinsonism (a review).
Topics: Acetylcholine; Animals; Atropa belladonna; Atropine; Central Nervous System; Chlorpromazine; Dextroa | 1968 |
9 trials available for chlorpromazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Kinematic analysis of the reach to grasp movement in Parkinson's and Huntington's disease subjects.
Topics: Adult; Age of Onset; Aged; Analysis of Variance; Antiparkinson Agents; Basal Ganglia; Chlorpromazine | 1998 |
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
Topics: Adolescent; Child; Chlorpromazine; Clinical Trials as Topic; Diagnosis, Differential; Dystonia Muscu | 1975 |
The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.
Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Behavior; Chlorpromazine; Clinical Trials | 1974 |
A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Benztropine; Capsules; Chlorpromazine; Clini | 1974 |
[Prophylaxis of neuroleptic parkonsonism with the Bulgarian drug INKhA-17 (Paabainkh) and bellazon].
Topics: Bulgaria; Chlorpromazine; Clinical Trials as Topic; Humans; Isoniazid; Mental Disorders; Parasympath | 1968 |
Brain amine concentrations after monoamine oxidase inhibitor administration.
Topics: Aged; Alkynes; Autopsy; Brain; Brain Stem; Caudate Nucleus; Chlorpromazine; Dopamine; Humans; Hypoth | 1972 |
Harmine antagonism of drug-induced extra-pyramidal disturbances.
Topics: Alkaloids; Anticonvulsants; Chlorpromazine; Clinical Trials as Topic; Encephalitis; Female; Humans; | 1964 |
Effects of L-DOPA on pharmacological parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Haloper | 1966 |
67 other studies available for chlorpromazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies.
Topics: alpha-Synuclein; Animals; Humans; Intrinsically Disordered Proteins; Mammals; Neurodegenerative Dise | 2022 |
Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Brain; Catalase; Catalepsy; Chitosan; Chl | 2019 |
Effects of rotigotine and rotigotine extended-release microsphere therapy on myocardial ischemic injury in mice.
Topics: Animals; Cardiotonic Agents; Chlorpromazine; Creatine Kinase, MB Form; Dopamine Agonists; Isoprotere | 2019 |
[Effect of largactil in parkinson syndrome].
Topics: Autonomic Agents; Chlorpromazine; Parkinson Disease | 1953 |
[Reversible parkinsonism in the course of largactil therapy of vomiting in pregnancy].
Topics: Chlorpromazine; Female; Parkinson Disease; Parkinsonian Disorders; Pregnancy; Pregnancy Complication | 1954 |
[Parkinsonian states appearing during chlorpromazine therapy].
Topics: Chlorpromazine; Parkinson Disease | 1954 |
[The effects of high-dosed reserpin (serpasil) treatment and drug-induced parkinsonism-like states on the electroencephalogram].
Topics: Antihypertensive Agents; Chlorpromazine; Electroencephalography; Humans; Parkinson Disease; Parkinso | 1955 |
[Hypothesis on the mechanism of action of chlorpromazine (largactil) on the extrapyramidal manifestations of the parkinsonian syndrome].
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders | 1955 |
[Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome].
Topics: Antihypertensive Agents; Chlorpromazine; Parkinson Disease; Rauwolfia; Reserpine; Schizophrenia; Sec | 1955 |
Parkinsonian reactions following chlorpromazine and reserpine; similar reactions in the same patients.
Topics: Antihypertensive Agents; Chlorpromazine; Parkinson Disease; Reserpine; Secologanin Tryptamine Alkalo | 1956 |
[Definition and mode of action of the psychomotor Parkinson syndrome therapeutically induced by serpasil and largactil].
Topics: Antihypertensive Agents; Chlorpromazine; Parkinson Disease; Reserpine; Secologanin Tryptamine Alkalo | 1956 |
Comments on the biological and psychopathological basis of individual variation in chlorpromazine therapy.
Topics: Chlorpromazine; Humans; Parkinson Disease; Psychopathology | 1956 |
Comments on the biological and psychopathological basis of individual variation in chlorpromazine therapy.
Topics: Chlorpromazine; Humans; Parkinson Disease; Psychopathology | 1956 |
Comments on the biological and psychopathological basis of individual variation in chlorpromazine therapy.
Topics: Chlorpromazine; Humans; Parkinson Disease; Psychopathology | 1956 |
Comments on the biological and psychopathological basis of individual variation in chlorpromazine therapy.
Topics: Chlorpromazine; Humans; Parkinson Disease; Psychopathology | 1956 |
Psychomotility and parkinsonism in treatment with neuroleptic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Electroconvulsive Therapy; Humans; Mental Disorders; Movement; | 1957 |
[BAL therapy in Parkinson's syndrome caused by largactil].
Topics: Chlorpromazine; Dimercaprol; Parkinson Disease | 1957 |
[Psychomotility, extrapyramidal syndrome and mode of action of neuroleptic therapies; chlorpromazine, reserpine and prochlorperazine].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Disease; Extrapyramidal Tracts; Humans | 1957 |
[Parkinsonism-like symptoms caused by chlorpromazine therapy].
Topics: Chlorpromazine; Electroconvulsive Therapy; Humans; Parkinson Disease; Parkinsonian Disorders; Psycho | 1958 |
[Contribution to the parkinsonian effects of chlorpromazine & reserpine].
Topics: Chlorpromazine; Humans; Parkinson Disease; Reserpine | 1958 |
[Treatment of parkinsonism-like syndromes caused by reserpine & chlorpromazine].
Topics: Chlorpromazine; Humans; Parkinson Disease; Parkinsonian Disorders; Piperidines; Reserpine; Syndrome | 1958 |
[Parkinson's disease treated with neuroleptics].
Topics: Antihypertensive Agents; Antipsychotic Agents; Chlorpromazine; Parkinson Disease; Secologanin Trypta | 1959 |
Reversibility of drug-induced parkinsonism.
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders; Reserpine | 1960 |
Theoretical considerations in parkinsonism induced by tranquilizing drugs.
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders; Reserpine; Tranquilizing Agents | 1959 |
[Experiences and conclusions in regard to the use of hirepin. Part I].
Topics: Chlorpromazine; Parkinson Disease; Perphenazine; Reserpine | 1960 |
Relationship between anti-acetylcholine and anti-Tremorine activity in anti-parkinsonian and related drugs.
Topics: Acetylcholine; Animals; Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Cholinergic Anta | 1962 |
[Chlorpromazine, Jendrassi's maneuver and parkinsonian rigor].
Topics: Chlorpromazine; Electroencephalography; Electromyography; Muscle Rigidity; Nervous System Physiologi | 1962 |
[Paradoxical parkinsonian syndrome after drug ingestion in a patient with portacaval anastomosis].
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders; Portacaval Shunt, Surgical | 1963 |
A study of drug-induced parkinsonism.
Topics: Chlorpromazine; Humans; Mental Disorders; Parkinson Disease; Parkinsonian Disorders; Prochlorperazin | 1963 |
[Occurrence and interpretation of psychomotor parkinsonism in megaphen or largactil prolonged therapy].
Topics: Chlorpromazine; Parkinson Disease; Parkinsonian Disorders | 1954 |
[Largactil (R.P.4560) in hypertonic and dyskinetic syndromes].
Topics: Chlorpromazine; Chorea; Dyskinesias; Humans; Movement Disorders; Parkinson Disease; Syndrome | 1954 |
[Parkinson like manifestations produced by medicamentation].
Topics: Antihypertensive Agents; Chlorpromazine; Humans; Parkinson Disease; Secologanin Tryptamine Alkaloids | 1955 |
[Parkinsonian syndrome following prolonged administration of chlorpromazine with fatal concomitant stroke. Appearance of pallidal lesions].
Topics: Basal Ganglia; Chlorpromazine; Ganglia; Globus Pallidus; Humans; Parkinson Disease; Parkinsonian Dis | 1959 |
Drug-induced extrapyramidal symptoms: their incidence and treatment.
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp | 1967 |
Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.
Topics: Aged; Antipsychotic Agents; Chlorpromazine; Haloperidol; Humans; Male; Middle Aged; Parkinson Diseas | 1982 |
[Huntington chorea: report of 16 cases].
Topics: Adult; Aged; Brain Diseases; Chlorpromazine; Dementia; Diagnosis, Differential; Female; gamma-Aminob | 1983 |
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; | 1982 |
Treatment of Parkinson's disease in a patient with acute intermittent porphyria.
Topics: Aged; Antiparkinson Agents; Benserazide; Chlorpromazine; Dopamine Antagonists; Drug Interactions; Fe | 1995 |
Prevalence and characteristics of patients with pseudoakathisia.
Topics: Adult; Akathisia, Drug-Induced; Antiparkinson Agents; Antipsychotic Agents; Chlorpromazine; Chronic | 2000 |
Dopamine-stimulated adenylate cyclase activity in the human brain: changes in Parkinsonism.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Aged; Brain; Caudate Nucleus; Chlorpromazine; Dopamine; F | 1978 |
"In vivo" release of endogenous neurotransmitters in cat limbic regions: effect of chlorpromazine and of electrical stimulation.
Topics: Acetylcholine; Animals; Cats; Chlorpromazine; Dopamine; Electric Stimulation; Female; Hippocampus; L | 1975 |
Parkinsonism: animal analogues of the human disorder.
Topics: Animals; Butyrophenones; Chlorpromazine; Disease Models, Animal; Haplorhini; Hydroxydopamines; Levod | 1976 |
[Interaction between L-dopa and other drugs].
Topics: Amantadine; Anti-Arrhythmia Agents; Apomorphine; Chlorpromazine; Drug Antagonism; Drug Interactions; | 1976 |
[The phenomenon of experimental motor retardation as one of the manifestations of the Parkinsonian syndrome].
Topics: Amphetamine; Animals; Catecholamines; Cats; Caudate Nucleus; Chlorpromazine; Dihydroergotoxine; Dise | 1975 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1992 |
H reflex suppression by thalamic stimulation and drug administration.
Topics: Chlorpromazine; Diazepam; Electric Stimulation; Humans; Motor Neurons; Muscle Spindles; Oscillometry | 1968 |
[Comparative biochemical studies in organic parkinsonian syndromes and drug induced parkinsonian syndromes].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biochemical Phenomena; Biochemistry; Chlorpromazi | 1966 |
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
Topics: Adult; Aged; Brain Damage, Chronic; Cheek; Chlorpromazine; Chlorprothixene; Clopenthixol; Female; Ha | 1967 |
Motor disturbance induced by tremorine and oxotremorine.
Topics: Acetylcholine; Amines; Animals; Atropine; Biperiden; Brain; Bridged-Ring Compounds; Chlorpromazine; | 1970 |
Actions of levodopa and dopamine in the central nervous system.
Topics: Animals; Apomorphine; Binding Sites; Brain; Central Nervous System; Chlorpromazine; Dihydroxyphenyla | 1971 |
Corpus striatum in paralysis agitans and in perphenazine-injected rats.
Topics: Aged; Amphetamine; Amphetamines; Animals; Basal Ganglia; Caudate Nucleus; Chlorpromazine; Corpus Str | 1974 |
A hypothesis on the preferential destruction of melanized tissues.
Topics: Cell Survival; Chlorpromazine; DNA; Dwarfism; Ear, Inner; Energy Transfer; Humans; Hypogonadism; Mel | 1974 |
The pharmacological control of growth hormone release. Studies on the action of L-dopa and chlorpromazine in normal subjects and patients with Parkinsonism, acromegaly and delayed onset of puberty.
Topics: Acromegaly; Chlorpromazine; Dihydroxyphenylalanine; Glucose Tolerance Test; Growth Hormone; Humans; | 1973 |
The control of melanocyte-stimulating hormone secretion.
Topics: Animals; Brain; Catecholamines; Chlorpromazine; Dihydroxyphenylalanine; Humans; Hypothalamus; Inject | 1973 |
Decreased dopamine and homovanillic acid excretion in a case with chlorpromazine-induced Parkinsonism.
Topics: Chlorpromazine; Dopamine; Homovanillic Acid; Humans; Male; Parkinson Disease; Parkinson Disease, Sec | 1973 |
Drug-induced experimental Parkinsonism.
Topics: Animals; Atropine; Benztropine; Butyrophenones; Cats; Chlorpromazine; Dose-Response Relationship, Dr | 1973 |
Effects of L-dopa and chlorpromazine on human growth hormone and TSH secretion in normal subjects and acromegalics.
Topics: Acromegaly; Adult; Chlorpromazine; Dihydroxyphenylalanine; Female; Glucose; Growth Hormone; Humans; | 1973 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; H | 1973 |
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose | 1974 |
The use of neuroleptic agents in a neurosurgical unit.
Topics: Benperidol; Cerebral Angiography; Chlorpromazine; Craniocerebral Trauma; Electrodes; Epilepsy; Fenta | 1969 |
Clinical implications of monoamine oxidase inhibition.
Topics: Brain; Brain Stem; Caudate Nucleus; Chlorpromazine; Depression; Dopamine; Drug Synergism; Humans; Hy | 1972 |
The effect of drugs inducing Parkinson's syndrome on muscle reflex mechanisms. A summary.
Topics: Animals; Chlorpromazine; Electrophysiology; Motor Neurons; Muscles; Parkinson Disease; Phenoxybenzam | 1965 |
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
Topics: Amines; Brain; Chlorpromazine; Extrapyramidal Tracts; Female; Humans; Hydroxyindoleacetic Acid; Move | 1970 |
[Pharmaco-biochemical mechanisms and modern therapy in Parkinsonian syndromes].
Topics: Animals; Central Nervous System; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tr | 1970 |
More on tick bite in Parkinson's disease.
Topics: Animals; Chlorpromazine; Dogs; Humans; Motor Activity; Parkinson Disease; Peripheral Nerves; Tick To | 1971 |
[On the clinical picture of current forms of epidemic encephalitis].
Topics: Adolescent; Adult; Autonomic Nervous System; Child; Chlorpromazine; Depersonalization; Encephalitis, | 1968 |
Antiparkinsonism medication for the phenothiazine-induced pyramidal-extrapyramidal syndrome in elderly brain-damaged patients.
Topics: Aged; Brain Damage, Chronic; Chlorpromazine; Female; Humans; Male; Parkinson Disease; Perphenazine; | 1965 |
[Comparative analysis of mechanical and electrical monosynaptic reflexes in patients with Parkinson's disease in various experimental conditions].
Topics: Chlorpromazine; Humans; Parkinson Disease; Phenothiazines; Reflex | 1964 |
[Etiology and therapy of Parkinson's syndrome and related pharmacological concepts shown in experimental models].
Topics: Animals; Brain Chemistry; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Humans; Hypothermia; Mic | 1966 |
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytic | 1966 |